Clinical Trial Information
Phase II/III Second-Line NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Ductal Adenocarcinoma (PLATINUM)
- Protocol Number: A022106
- Status: Open
- Age Group: Adult
- Treatment Type: Treatment
- Phase: II/III
- NCT ID: NCT06115499
Scope Information
- Scope:
- National
- Disease Site(s):
- Pancreas
